[go: up one dir, main page]

GB1265332A - - Google Patents

Info

Publication number
GB1265332A
GB1265332A GB1265332DA GB1265332A GB 1265332 A GB1265332 A GB 1265332A GB 1265332D A GB1265332D A GB 1265332DA GB 1265332 A GB1265332 A GB 1265332A
Authority
GB
United Kingdom
Prior art keywords
alkyl
formula
cephalosporins
phenyl
atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1265332A publication Critical patent/GB1265332A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/60Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 3 and 4
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

1,265,332. #<SP>2</SP>-Cephalosporins. ELI LILLEY & CO. 7 Feb., 1969 [7 Feb., 1968; 13 Jan., 1969 (2)], No. 6824/69. Heading C2A. Novel #<SP>2</SP>-cephalosporins of Formula I wherein R is trimethylsilyl, triphenylmethyl, butoxycarbonyl, phenoxyacetyl, phenylacetyl, phenylmercaptoacetyl or phenyl-α,α-dimethylacetyl, or a phenoxyacetyl, phenylacetyl, phenylmercaptoacetyl or phenyl - α,α - dimethylacetyl group ring substituted with F, Cl, Br, I, NO 2 , CN, CF 3 , C 1 to C 6 alkyl, C 1 to C 2 alkoxy or butoxycarbonylmethyl; R<SP>11</SP> is CN or XY where X is O or S and Y is C 1 to C 10 alkyl, C 3 to C 10 alkenyl, C 3 to C 15 alkynyl, C 5 to C 7 cycloalkyl, C 3 to C 6 cycloalkyl-C 1 to C 6 alkyl, C 2 to C 10 haloalkyl, C 3 to C 10 haloalkenyl, C 3 to C 10 haloalkynyl, C 1 to C 3 cyanoalkyl, C 1 to C 3 alkyl-X-C 1 to C 6 alkyl where X is O or S, C 1 to C 6 alkoxycarbonyl-C 1 to C 6 alkyl, C 2 to C 4 alkanoyl-C 1 to C 6 alkyl, C 2 to C 4 alkanoyloxy- C 1 -C 6 alkyl, (2<SP>1</SP>-tetrahydrofuryl)-C 1 to C 3 alkyl, 31-tetrahydrofuryl, (2<SP>1</SP>-thienyl)-C 1 to C 3 alkyl, phenyl-C 1 to C 3 alkyl, or a phenyl, benzyl or phenethyl group which may be substituted with CN, NO 2 , CF 3 , C 1 to C 3 alkyl, C 1 to C 3 alkoxy or C 1 to C 3 alkoxycarbonyl, or R<SP>11</SP> is where R<SP>3</SP> and R<SP>4</SP> are each C 1 to C 6 alkyl or together with the common N atom complete a 5 to 6 ring atom-containing heterocycle of formula in which n is 0 or 1 and Q is -CH 2 -, -O-, -S- or where R<SP>6</SP> is H or C 1 to C 4 alkyl, except that when n is 0, Q is -CH 2 -; and R<SP>1</SP> is C 4 to C 6 tert. alkyl, C 5 to C 7 tert. alkynyl, benzyl, methoxybenzyl, nitrobenzyl, phenacyl, trimethylsilyl, benzhydryl, phthalimidomethyl or succinimidomethyl, are prepared by reacting N-bromosuccinimide with a 3-desacetoxy-#<SP>2</SP>-cephalosporin of Formula III in an anhydrous organic solvent at about 40‹ to 100‹ C. to give a novel 3-bromomethyl-#<SP>2</SP>- cephalosporin of Formula IV which compound is then reacted with an appropriate nucleophilic reagent to replace the bromine atom by the group R<SP>11</SP>. The starting cephalosporins III may be prepared by hydrogenating a #<SP>3</SP>-cephalosporin ester to form the corresponding #<SP>3</SP>-desacetoxycephalosporin ester which is treated with a base such as pyridine in the cold to isomerize the #<SP>3</SP> double bond to the #<SP>2</SP> position. In addition to the #<SP>2</SP> compounds of Formula I, the inventive process may form some of the corresponding #<SP>3</SP> cephalosporins due to the basic conditions which may be used in the nucleophilic displacement of the Br atom. Alternatively the #<SP>2</SP> compounds may be converted to corresponding #<SP>3</SP> compounds by oxidation to the #<SP>3</SP> sulphoxide which is subsequently reduced, according to Specification 1,265,333.
GB1265332D 1968-02-07 1969-02-07 Expired GB1265332A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70352368A 1968-02-07 1968-02-07
US79088669A 1969-01-13 1969-01-13
US79084269A 1969-01-13 1969-01-13

Publications (1)

Publication Number Publication Date
GB1265332A true GB1265332A (en) 1972-03-01

Family

ID=27418758

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1265333D Expired GB1265333A (en) 1968-02-07 1969-02-07
GB1265332D Expired GB1265332A (en) 1968-02-07 1969-02-07

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB1265333D Expired GB1265333A (en) 1968-02-07 1969-02-07

Country Status (11)

Country Link
JP (3) JPS524558B1 (en)
BE (1) BE728053A (en)
CH (1) CH534694A (en)
DK (1) DK140726B (en)
FI (1) FI56535C (en)
FR (3) FR2001491B1 (en)
GB (2) GB1265333A (en)
IL (2) IL40447A (en)
LU (1) LU57932A1 (en)
NL (1) NL173407C (en)
SE (3) SE384511B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2132883A1 (en) * 1970-07-08 1972-01-13 Ciba Geigy Ag Cephem compounds
JPS53164082U (en) * 1977-05-31 1978-12-22
JPS5899787U (en) * 1981-12-28 1983-07-07 奥野電器株式会社 lamp socket
EP0300546B1 (en) * 1987-07-10 1995-08-09 Gist-Brocades N.V. Process for the preparation of cephem compounds and cephalosporin derivatives

Also Published As

Publication number Publication date
FI56535C (en) 1980-02-11
JPS4924076B1 (en) 1974-06-20
FR2095486A5 (en) 1972-02-11
LU57932A1 (en) 1969-09-17
FR2001491B1 (en) 1973-07-13
IL40447A (en) 1976-02-29
SE407064B (en) 1979-03-12
NL6902013A (en) 1969-08-11
DK140726B (en) 1979-11-05
GB1265333A (en) 1972-03-01
DK140726C (en) 1980-03-31
FR2085656A1 (en) 1971-12-31
SE418616B (en) 1981-06-15
SE7512818L (en) 1975-11-14
FR2001491A1 (en) 1969-09-26
FR2085656B1 (en) 1974-08-23
JPS524558B1 (en) 1977-02-04
FI56535B (en) 1979-10-31
SE384511B (en) 1976-05-10
JPS524559B1 (en) 1977-02-04
BE728053A (en) 1969-08-07
CH534694A (en) 1973-03-15
NL173407C (en) 1984-01-16
IL41553A (en) 1976-02-29
NL173407B (en) 1983-08-16

Similar Documents

Publication Publication Date Title
ES378765A1 (en) 3 7-(ring-substituted) cephalosporin compounds
IE781140L (en) Penicillanic acid s-oxides
DE2258221A1 (en) PROCESS FOR PREPARING NOVEL ANTIBIOTIC COMPOUNDS
IE792222L (en) Azathiabicycloheptane derivatives
ES2043807T3 (en) ANTICANCER COMPOUNDS.
GB1265332A (en)
IE36638L (en) Preparing cephalosporins from penicillanic sulphoxides
JPS5615292A (en) Novel betaalactam compound
DE2754743A1 (en) THIOOXIMCEPHALOSPORIN AND PENICILLIN DERIVATIVES, PROCESS FOR THEIR MANUFACTURING AND THEIR USE AS MEDICINAL SUBSTANCES
ES371709A1 (en) Synthetic penicillins
DE2323395A1 (en) PROCESS FOR THE MANUFACTURING OF DESACETOXYCEPHALOSPORINES AND NEW INTERMEDIATE PRODUCTS
DE2633005A1 (en) CEPHEM AND PENAM COMPOUNDS AND PROCEDURES FOR THEIR PRODUCTION
US4159267A (en) Novel silyl ester azetidine-2-sulfenate intermediates and process for preparing desacetoxycephalosporins
GB1211694A (en) Derivatives of 7-aminocephalosporanic acid
IE781325L (en) Azetidinones.
AT331408B (en) PROCESS FOR MANUFACTURING A NEW INTERMEDIATE
IE33417L (en) Cephalosporin sulphoxide
US4176231A (en) Process for preparing 3-exomethylenecepham sulfoxides
ES406344A1 (en) Process for 7-aminocephalosporanic acid
GB1130370A (en) Esters of 6-aminopenicillanic acid
KR810001264B1 (en) Preparation of 2-alkyl-7-substituted-2 (or 3) -cefe-4-carboxylic acids
FR2381750A1 (en) PHENYLACETONITRIL SUBSTITUTES AND THEIR PREPARATION
GB1295908A (en)
GB1312030A (en) Penicillin compounds and a method of synthesising same
ES440054A1 (en) A procedure for the preparation of cephalosporins. (Machine-translation by Google Translate, not legally binding)

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years